KR101850648B1 - 피부보습 및 재생 촉진활성을 갖는 녹차유래의 다당체를 함유하는 화장료 조성물 및 그 제조방법 - Google Patents
피부보습 및 재생 촉진활성을 갖는 녹차유래의 다당체를 함유하는 화장료 조성물 및 그 제조방법 Download PDFInfo
- Publication number
- KR101850648B1 KR101850648B1 KR1020170057082A KR20170057082A KR101850648B1 KR 101850648 B1 KR101850648 B1 KR 101850648B1 KR 1020170057082 A KR1020170057082 A KR 1020170057082A KR 20170057082 A KR20170057082 A KR 20170057082A KR 101850648 B1 KR101850648 B1 KR 101850648B1
- Authority
- KR
- South Korea
- Prior art keywords
- green tea
- polysaccharide
- skin
- enzyme
- derived
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 244000269722 Thea sinensis Species 0.000 title claims abstract description 57
- 235000009569 green tea Nutrition 0.000 title claims abstract description 55
- 150000004676 glycans Chemical class 0.000 title claims abstract description 48
- 229920001282 polysaccharide Polymers 0.000 title claims abstract description 48
- 239000005017 polysaccharide Substances 0.000 title claims abstract description 48
- 239000000203 mixture Substances 0.000 title claims abstract description 23
- 239000002537 cosmetic Substances 0.000 title claims abstract description 21
- 230000036560 skin regeneration Effects 0.000 title claims abstract description 15
- 230000001737 promoting effect Effects 0.000 title claims abstract description 14
- 102000004190 Enzymes Human genes 0.000 title claims description 31
- 108090000790 Enzymes Proteins 0.000 title claims description 31
- 239000000284 extract Substances 0.000 title description 4
- 238000002360 preparation method Methods 0.000 title description 3
- 238000004519 manufacturing process Methods 0.000 claims abstract description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 35
- 229940094952 green tea extract Drugs 0.000 claims description 31
- 235000020688 green tea extract Nutrition 0.000 claims description 31
- 229940088598 enzyme Drugs 0.000 claims description 30
- 238000006911 enzymatic reaction Methods 0.000 claims description 21
- 239000007795 chemical reaction product Substances 0.000 claims description 19
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 claims description 12
- 235000005487 catechin Nutrition 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 12
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 claims description 9
- 229950001002 cianidanol Drugs 0.000 claims description 9
- 239000000843 powder Substances 0.000 claims description 9
- 239000006228 supernatant Substances 0.000 claims description 9
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 claims description 8
- 238000000194 supercritical-fluid extraction Methods 0.000 claims description 8
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 claims description 6
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims description 6
- 238000006243 chemical reaction Methods 0.000 claims description 6
- 108010059892 Cellulase Proteins 0.000 claims description 5
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 claims description 5
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims description 5
- 101710130006 Beta-glucanase Proteins 0.000 claims description 4
- 101710121765 Endo-1,4-beta-xylanase Proteins 0.000 claims description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 4
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 claims description 4
- 108010059820 Polygalacturonase Proteins 0.000 claims description 4
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 claims description 4
- 229960001948 caffeine Drugs 0.000 claims description 4
- 229940106157 cellulase Drugs 0.000 claims description 4
- 239000008103 glucose Substances 0.000 claims description 4
- 229940059442 hemicellulase Drugs 0.000 claims description 4
- 108010002430 hemicellulase Proteins 0.000 claims description 4
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 claims description 3
- PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 claims description 3
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 claims description 3
- 229930182830 galactose Natural products 0.000 claims description 3
- 239000012466 permeate Substances 0.000 claims description 3
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 claims description 2
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 claims description 2
- 238000001556 precipitation Methods 0.000 claims description 2
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 claims 2
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 claims 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims 2
- 229920000936 Agarose Polymers 0.000 claims 1
- 239000007864 aqueous solution Substances 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 210000003491 skin Anatomy 0.000 abstract description 26
- 210000002510 keratinocyte Anatomy 0.000 abstract description 18
- 230000000694 effects Effects 0.000 abstract description 11
- 239000004480 active ingredient Substances 0.000 abstract description 9
- 230000004069 differentiation Effects 0.000 abstract description 9
- 230000007935 neutral effect Effects 0.000 abstract description 9
- 230000035755 proliferation Effects 0.000 abstract description 8
- 239000004615 ingredient Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 16
- 235000000346 sugar Nutrition 0.000 description 14
- 150000008442 polyphenolic compounds Chemical class 0.000 description 12
- 235000013824 polyphenols Nutrition 0.000 description 12
- 239000000376 reactant Substances 0.000 description 11
- 241000196324 Embryophyta Species 0.000 description 9
- 210000004027 cell Anatomy 0.000 description 9
- 230000003020 moisturizing effect Effects 0.000 description 9
- 230000002062 proliferating effect Effects 0.000 description 8
- 230000001965 increasing effect Effects 0.000 description 7
- 239000008213 purified water Substances 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- 210000000434 stratum corneum Anatomy 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 150000008163 sugars Chemical class 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 239000002253 acid Substances 0.000 description 5
- 150000001413 amino acids Chemical class 0.000 description 5
- 210000002421 cell wall Anatomy 0.000 description 5
- 238000009826 distribution Methods 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 239000011888 foil Substances 0.000 description 5
- 108090000765 processed proteins & peptides Proteins 0.000 description 5
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 description 4
- 108010029182 Pectin lyase Proteins 0.000 description 4
- 230000004663 cell proliferation Effects 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 230000014509 gene expression Effects 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 239000012535 impurity Substances 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 238000000134 MTT assay Methods 0.000 description 3
- 231100000002 MTT assay Toxicity 0.000 description 3
- 150000001765 catechin Chemical class 0.000 description 3
- 239000000470 constituent Substances 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 230000009759 skin aging Effects 0.000 description 3
- 238000000638 solvent extraction Methods 0.000 description 3
- 108010075550 termamyl Proteins 0.000 description 3
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 description 2
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- 239000004382 Amylase Substances 0.000 description 2
- 241000228212 Aspergillus Species 0.000 description 2
- 241000228215 Aspergillus aculeatus Species 0.000 description 2
- 108090000695 Cytokines Proteins 0.000 description 2
- 102000004127 Cytokines Human genes 0.000 description 2
- 239000001263 FEMA 3042 Substances 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 101500025419 Homo sapiens Epidermal growth factor Proteins 0.000 description 2
- 102100034343 Integrase Human genes 0.000 description 2
- 102100023970 Keratin, type I cytoskeletal 10 Human genes 0.000 description 2
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 2
- 108091000080 Phosphotransferase Proteins 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 229930002875 chlorophyll Natural products 0.000 description 2
- 235000019804 chlorophyll Nutrition 0.000 description 2
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000002500 effect on skin Effects 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 229940075529 glyceryl stearate Drugs 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 229940116978 human epidermal growth factor Drugs 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- GVUGOAYIVIDWIO-UFWWTJHBSA-N nepidermin Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C(C)C)C(C)C)C1=CC=C(O)C=C1 GVUGOAYIVIDWIO-UFWWTJHBSA-N 0.000 description 2
- 230000037311 normal skin Effects 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- 102000020233 phosphotransferase Human genes 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 230000001172 regenerating effect Effects 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 230000037380 skin damage Effects 0.000 description 2
- 230000036620 skin dryness Effects 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000001694 spray drying Methods 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 229920002258 tannic acid Polymers 0.000 description 2
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 2
- 229940033123 tannic acid Drugs 0.000 description 2
- 235000015523 tannic acid Nutrition 0.000 description 2
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 1
- 102100027324 2-hydroxyacyl-CoA lyase 1 Human genes 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 241000228245 Aspergillus niger Species 0.000 description 1
- PYIXHKGTJKCVBJ-UHFFFAOYSA-N Astraciceran Natural products C1OC2=CC(O)=CC=C2CC1C1=CC(OCO2)=C2C=C1OC PYIXHKGTJKCVBJ-UHFFFAOYSA-N 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- NDVRQFZUJRMKKP-UHFFFAOYSA-N Betavulgarin Natural products O=C1C=2C(OC)=C3OCOC3=CC=2OC=C1C1=CC=CC=C1O NDVRQFZUJRMKKP-UHFFFAOYSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 235000009024 Ceanothus sanguineus Nutrition 0.000 description 1
- 108050006400 Cyclin Proteins 0.000 description 1
- AEMOLEFTQBMNLQ-YMDCURPLSA-N D-galactopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-YMDCURPLSA-N 0.000 description 1
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- 101001009252 Homo sapiens 2-hydroxyacyl-CoA lyase 1 Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 108090001005 Interleukin-6 Proteins 0.000 description 1
- 108090001007 Interleukin-8 Proteins 0.000 description 1
- 102100022905 Keratin, type II cytoskeletal 1 Human genes 0.000 description 1
- 102100025756 Keratin, type II cytoskeletal 5 Human genes 0.000 description 1
- 108010070514 Keratin-1 Proteins 0.000 description 1
- 108010065038 Keratin-10 Proteins 0.000 description 1
- 108010070553 Keratin-5 Proteins 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- XMOCLSLCDHWDHP-UHFFFAOYSA-N L-Epigallocatechin Natural products OC1CC2=C(O)C=C(O)C=C2OC1C1=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-UHFFFAOYSA-N 0.000 description 1
- 240000003553 Leptospermum scoparium Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 102000018697 Membrane Proteins Human genes 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- IHPVFYLOGNNZLA-UHFFFAOYSA-N Phytoalexin Natural products COC1=CC=CC=C1C1OC(C=C2C(OCO2)=C2OC)=C2C(=O)C1 IHPVFYLOGNNZLA-UHFFFAOYSA-N 0.000 description 1
- 102000009339 Proliferating Cell Nuclear Antigen Human genes 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 238000011529 RT qPCR Methods 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- 102000004338 Transferrin Human genes 0.000 description 1
- 108090000901 Transferrin Proteins 0.000 description 1
- 241000499912 Trichoderma reesei Species 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
- 102100040247 Tumor necrosis factor Human genes 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000000489 anti-atherogenic effect Effects 0.000 description 1
- 101150036080 at gene Proteins 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 229940088623 biologically active substance Drugs 0.000 description 1
- LLEMOWNGBBNAJR-UHFFFAOYSA-N biphenyl-2-ol Chemical group OC1=CC=CC=C1C1=CC=CC=C1 LLEMOWNGBBNAJR-UHFFFAOYSA-N 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical group 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 229940081733 cetearyl alcohol Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000007810 chemical reaction solvent Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000005712 elicitor Substances 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 229940100524 ethylhexylglycerin Drugs 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000010195 expression analysis Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000003633 gene expression assay Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000010903 husk Substances 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 229940100460 peg-100 stearate Drugs 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- OQUKIQWCVTZJAF-UHFFFAOYSA-N phenol;sulfuric acid Chemical compound OS(O)(=O)=O.OC1=CC=CC=C1 OQUKIQWCVTZJAF-UHFFFAOYSA-N 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000000280 phytoalexin Substances 0.000 description 1
- 150000001857 phytoalexin derivatives Chemical class 0.000 description 1
- 230000001817 pituitary effect Effects 0.000 description 1
- 244000000003 plant pathogen Species 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000012925 reference material Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 102000037983 regulatory factors Human genes 0.000 description 1
- 108091008025 regulatory factors Proteins 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000004317 sodium nitrate Substances 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 239000012581 transferrin Substances 0.000 description 1
- 150000003852 triazoles Chemical class 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 230000037373 wrinkle formation Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/66—Enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
도2는 본 발명예 따른 각종 효소의 반응시간에 따른 녹차 효소반응물의 당 수치를 나타낸 그래프이다.
도3은 본 발명예 따른 녹차 효소반응물의 GPC분석 크로마토그래프를 나타낸 사진도이다.
도4는 본 발명예 따른 녹차 효소반응물의 인간 각질형성세포에 대한 증식능 평가를 나타낸 그래프이다.
도5는 본 발명예 따른 녹차 효소반응물의 Fr2 분획물의 GPC분석 크로마토그래프를 나타낸 사진도이다.
도6은 본 발명예 따른 녹차 효소반응물 분획물의 인간 각질형성세포에 대한 증식능 평가를 나타낸 그래프이다.
도7은 본 발명예 따른 녹차 효소반응물 분획물의 피부재생 촉진 증식능 평가를 나타낸 사진도 및 그래프이다.
도8은 본 발명예 따라 제조된 크림을 정상 피부에 도포한 후 피부의 수분함량의 경시적 변화를 보인 그림이다.
도9는 본 발명예 따라 제조된 크림을 정상 피부에 도포한 후 24시간 지속력을 실험한 보습 지속력 시험 결과이다.
| 추출방법 | 샘플명 | 수득량(g) | 카테킨 함량(%) | 총 카테킨양(g) |
| 용매추출 | 녹차카테킨-60에탄올 | 31.4 | 29.9 | 9.4 |
| 초임계추출 | 녹차카테킨-SFE | 36.7 | 31.1 | 11.4 |
| 녹차박 추출액 | 초임계추출-녹차박 유래 | 60%EtOH-녹차추출잔사 유래 | |||
| 폴리페놀(%) | 0.20 | 1.95 | |||
| 카테킨(%) | EGC | 0.000 | 0.000 | 0.040 | 0.020 |
| EC | 0.000 | 0.000 | |||
| EGCG | 0.000 | 0.020 | |||
| ECG | 0.000 | 0.000 | |||
| 카페인(%) | 0.000 | 0.010 | |||
| 녹차조다당 수율(%) | 7.4 | 7.7 | |||
| 효소명 | 주요활성 | 기원 | 최적 온도(℃) | 최적 pH |
| Pectinex® Ultra SP-L | polygalacturonase | Aspergillus aculeatus | 35 | 3.5~4.5 |
| Pectinex® Ultra MASH | pectin lyase | Aspergillus aculeatus, Aspergillus niger | 10~60 | 3.0~4.2 |
| Termamyl 120L Type L | a-amylase | Bacillus lichniformis | Heat stable | 5.5~6.5 |
| Multifect PR6L |
endogenous protease | - | 50~60 | 8.0 |
| Spezyme LT300 |
a-amylase |
Bacillus subtilis | 25 | 5.5~6.0 |
| Viscozyme L | beta-glucanase (endo-1,3(4)-), Xylanase, cellulase, hemicellulase, arabinase | Aspergillus aculaeatus |
25~55 | 3.3~5.5 |
| Celluclast TM 1.5L | endoglucanase | Trichoderma reesei (fungus) | 50~60 | 4.5~6.0 |
| 컬럼 | Shodex사, Asahipak. GS 520HQ + GS 320HQ + GS 220HQ (7.5mm ID X 300mm) |
| 온도 | 30℃ |
| 유속 | 0.5ml/min |
| 유속 | 100mM Sodium nitrate (isocratic) |
| 주입량 | 20㎕ |
| 검출기 | Waters 410W, RI detector |
| 산성당 (%) |
중성당 (%) |
아미노산 (%) |
펩타이드(%) | 폴리페놀 (%) |
|
| 대조군 | 46.2 | 39.2 | 1.9 | 10.8 | 1.8 |
| Pectinex® Ultra SP-L 처리군 | 36.3 | 51.4 | 1.9 | 9.0 | 1.4 |
| Viscozyme L 처리군 | 31.7 | 55.0 | 1.9 | 9.8 | 1.6 |
| Pectinex® Ultra MASH 처리군 | 34.0 | 52.5 | 1.9 | 10.5 | 1.2 |
| 산성당 (%) |
중성당 (%) |
아미노산 (%) |
펩타이드(%) | 폴리페놀 (%) |
|
| 효소반응물 | 36.3 | 51.4 | 1.9 | 9.0 | 1.4 |
| F1 분획 | 11.2 | 76.9 | 0.0 | 10.5 | 1.3 |
| F2 분획 | 86.5 | 7.4 | 0.0 | 5.7 | 0.4 |
| F3 분획 | 28.5 | 59.5 | 0.0 | 11.0 | 0.9 |
| 구성당 | GT polysaccharide (mole %) |
| Rhamnose | 6.4 |
| Fucose | 1.1 |
| Arabinose | 21.9 |
| Xylose | 5.4 |
| Mannose | 2.3 |
| Galactose | 17.8 |
| Glucose | 45.1 |
| 소계 | 100.0 |
| 원료(INCI name) | 시험시료 (단위: 중량%) |
대조시료 (단위: 중량%) |
| Water | 73.93 | 74.43 |
| Disodium EDTA | 0.02 | 0.02 |
| Carbomer (2%) | 15.00 | 15.00 |
| 본 발명 녹차유래 다당체 조성물 | 0.50 | 0.00 |
| Cetearyl Alcohol | 2.00 | 2.00 |
| Paraffinum Liquidum | 5.00 | 5.00 |
| Glyceryl Stearate (and) PEG-100 Stearate | 1.00 | 1.00 |
| Glyceryl Stearate | 0.50 | 0.50 |
| Dimethicone | 0.20 | 0.20 |
| Ethylhexylglycerin | 0.20 | 0.20 |
| Water | 1.00 | 1.00 |
| Triethanolamine | 0.35 | 0.35 |
| Phenoxyethanol | 0.30 | 0.30 |
| 합계 | 100 | 100 |
| 시험 전 | 2주 후 | 4주 후 | |
| 대조군 | 0.0 | 5.8 | 13.9 |
| 본 발명 녹차유래 다당체 조성물 |
0.0 | 8.6 | 22.9 |
Claims (7)
- 녹차잎분말에서 카테킨, 카페인 및 왁스성분을 초임계추출하여 제거한 녹차추출박에 효소를 처리하여 효소반응물을 수득하는 단계와 상기 단계에서 얻은 효소반응물을 원심분리하여 상등액을 얻는 단계와 상기 단계에서 얻은 상등액을 에탄올 수용액으로 침전반응시키고 투석하여 투과액을 회수하는 단계로 이루어진 녹차잎 유래의 다당체를 제조 방법에 있어서,
상기 녹차추출박은 80 bar, 70°C 조건의 초임계추출기를 이용하여 얻은 녹차추출박이고, 상기 효소는 폴리갈락투로네이즈(polygalacturonase), 베타글루카네이즈(beta-glucanase), 자일라네이즈(Xylanase), 셀룰레이즈(cellulase), 헤미셀룰레이즈(hemicellulase) 및 아라비네이즈(arabinase) 중에서 선택되는 것이 특징인 녹차잎 유래의 저분자 다당체 제조 방법.
- 제1항에 있어서, 상기 저분자 다당체는 분자량이 1,000~3,500Da 범위의 람노오스, 푸코오스, 아라비노오스, 자일로스, 만노즈, 갈락토즈 및 글루코즈를 함유하는 것이 특징인 방법.
- 삭제
- 제1항 또는 제2항의 방법에 따라 제조된 녹차잎 유래의 저분자 다당체.
- 제4항의 녹차잎 유래의 저분자 다당체를 함유하는 피부재생 촉진용 화장료 조성물.
- 제5항에 있어서, 상기 다당체는 람노오스 6.4mole%, 푸코오스 1.1mole%, 아라비노오스 21.9mole%, 자일로스 5.4mole%, 만노즈 2.3mole%, 갈락토즈 17.8mole% 및 글루코즈 45.1mole%로 이루어진 것이 특징인 피부 재생 촉진용 화장료 조성물.
- 삭제
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/KR2017/004729 WO2017192024A1 (ko) | 2016-05-03 | 2017-05-04 | 피부보습 및 재생 촉진활성을 갖는 녹차유래의 올리고당을 함유하는 화장료 조성물 및 그 제조방법 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20160054830 | 2016-05-03 | ||
| KR1020160054830 | 2016-05-03 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20170124976A KR20170124976A (ko) | 2017-11-13 |
| KR101850648B1 true KR101850648B1 (ko) | 2018-04-19 |
Family
ID=60386111
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020170057082A Active KR101850648B1 (ko) | 2016-05-03 | 2017-05-04 | 피부보습 및 재생 촉진활성을 갖는 녹차유래의 다당체를 함유하는 화장료 조성물 및 그 제조방법 |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR101850648B1 (ko) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102072947B1 (ko) | 2019-08-06 | 2020-02-04 | 주식회사 씨엔엘바이오텍 | 상처치유 또는 피부재생 촉진용 약학 조성물 |
| KR20210093669A (ko) | 2020-01-20 | 2021-07-28 | 동의대학교 산학협력단 | 불가사리 추출물을 유효성분으로 포함하는 피부 재생 및 피부 보습용 조성물 |
| KR102331412B1 (ko) | 2020-07-31 | 2021-12-02 | 동의대학교 산학협력단 | 달맞이 꽃 추출물을 포함하고 초기 개선 활성이 우수한 피부 재생 및 피부 보습용 조성물 |
| KR20230048887A (ko) | 2021-10-05 | 2023-04-12 | 동의대학교 산학협력단 | 카칼리아 추출물을 유효 성분으로 포함하는 피부 자극이 없고, 피부 보습이 우수한 조성물 |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102110081B1 (ko) * | 2019-07-29 | 2020-05-22 | (주)이시스코스메틱 | 복합 효소를 이용한 혼합 추출물을 함유하는 모공 수축 및 항산화용 화장료 조성물 |
| KR102721819B1 (ko) * | 2021-11-24 | 2024-10-25 | 주식회사 아이씨바이오 | 녹차 뿌리 다당체를 함유하는 피부 보습 또는 피부 장벽 강화용 조성물 및 이의 제조방법 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2011529045A (ja) | 2008-07-22 | 2011-12-01 | 株式會社アモーレパシフィック | 緑茶多糖体の製造方法並びにこれを含有する皮膚美白、保湿及びしわ改善用化粧料組成物 |
-
2017
- 2017-05-04 KR KR1020170057082A patent/KR101850648B1/ko active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2011529045A (ja) | 2008-07-22 | 2011-12-01 | 株式會社アモーレパシフィック | 緑茶多糖体の製造方法並びにこれを含有する皮膚美白、保湿及びしわ改善用化粧料組成物 |
| JP5756753B2 (ja) * | 2008-07-22 | 2015-07-29 | 株式会社アモーレパシフィックAmorepacific Corporation | 緑茶多糖体の製造方法並びにこれを含有する皮膚美白、保湿及びしわ改善用化粧料組成物 |
Non-Patent Citations (1)
| Title |
|---|
| 한국식품영양과학회지,44권,5호, 664-672면 (2015.05.01.)* |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102072947B1 (ko) | 2019-08-06 | 2020-02-04 | 주식회사 씨엔엘바이오텍 | 상처치유 또는 피부재생 촉진용 약학 조성물 |
| KR20210093669A (ko) | 2020-01-20 | 2021-07-28 | 동의대학교 산학협력단 | 불가사리 추출물을 유효성분으로 포함하는 피부 재생 및 피부 보습용 조성물 |
| KR102331412B1 (ko) | 2020-07-31 | 2021-12-02 | 동의대학교 산학협력단 | 달맞이 꽃 추출물을 포함하고 초기 개선 활성이 우수한 피부 재생 및 피부 보습용 조성물 |
| KR20230048887A (ko) | 2021-10-05 | 2023-04-12 | 동의대학교 산학협력단 | 카칼리아 추출물을 유효 성분으로 포함하는 피부 자극이 없고, 피부 보습이 우수한 조성물 |
Also Published As
| Publication number | Publication date |
|---|---|
| KR20170124976A (ko) | 2017-11-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101850648B1 (ko) | 피부보습 및 재생 촉진활성을 갖는 녹차유래의 다당체를 함유하는 화장료 조성물 및 그 제조방법 | |
| KR20100010132A (ko) | 녹차다당체의 제조방법 | |
| KR102085559B1 (ko) | 은이 버섯 추출물, 이의 제조방법 및 이의 용도 | |
| CN110278706B (zh) | 包含使用冠突曲霉菌株发酵的发酵大豆的提取物的皮肤美容改善用组合物 | |
| JP2011088845A (ja) | インボルクリン発現抑制剤 | |
| KR101814498B1 (ko) | 유칼립투스 잎과 붉은토끼풀 잎의 혼합 추출물을 함유하는 화장료 조성물 | |
| WO2022004669A1 (ja) | Ccn1及びccn2の発現を増加させるための皮膚適用用組成物 | |
| KR102721819B1 (ko) | 녹차 뿌리 다당체를 함유하는 피부 보습 또는 피부 장벽 강화용 조성물 및 이의 제조방법 | |
| KR20080049352A (ko) | 틸리아닌( tilianin) 또는아카세틴(acacetin)을 유효성분으로 함유하는화장료 조성물 | |
| US20230390234A1 (en) | Composition inhibiting muscle loss or promoting muscle formation through skin-derived exosomes | |
| KR101655878B1 (ko) | 세리포리아 락세라타에 의해 생산되는 세포외다당체를 유효성분으로 함유하는 탈모방지 또는 발모촉진용 조성물 | |
| KR20150081892A (ko) | 돼지감자 추출물을 함유하는 화장료 조성물 | |
| KR20120054298A (ko) | 발효 콩잎 추출물을 유효성분으로 함유하는 피부 외용제 조성물 | |
| KR20110116389A (ko) | 알로에와 천마 발효여과물을 함유하는 피부 외용제 조성물 | |
| KR101824179B1 (ko) | 더위지기 효모 발효물을 포함하는 보습 및 항염증 화장료 조성물 | |
| KR101805872B1 (ko) | 엽록소가 제거된 식물추출물을 유효성분으로 함유하는 주름 개선용 화장료 조성물 | |
| CN104337731A (zh) | 神经酰胺和/或葡萄糖神经酰胺产生促进剂或者保湿剂 | |
| CN112870298A (zh) | 一种铁皮石斛原液及其制备方法和应用 | |
| Kim et al. | The protective effect of alfalfa (Medicago sativa L.) seed extract containing polysaccharides on human keratinocytes and fibroblasts | |
| KR102477052B1 (ko) | 선복화 단백다당체 또는 선복화 올리고당/펩타이드 복합체를 유효성분으로 함유하는 피부 외용제 조성물 및 이의 제조방법 | |
| KR20180050624A (ko) | 식물 추출물로부터 엽록소 또는 색소를 제거하는 방법 | |
| EP4501340A1 (en) | Method for producing ellagic acid-containing composition and ellagic acid-containing composition | |
| KR100864852B1 (ko) | 소수성이 개선된 상엽 추출물의 제조방법 | |
| WO2017192024A1 (ko) | 피부보습 및 재생 촉진활성을 갖는 녹차유래의 올리고당을 함유하는 화장료 조성물 및 그 제조방법 | |
| KR101957426B1 (ko) | 황금 추출물의 붉은덕다리버섯 균사체 발효물을 함유하는 자외선에 의한 피부 손상 억제용 화장료 조성물 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20170504 |
|
| PA0201 | Request for examination | ||
| A302 | Request for accelerated examination | ||
| PA0302 | Request for accelerated examination |
Patent event date: 20170510 Patent event code: PA03022R01D Comment text: Request for Accelerated Examination Patent event date: 20170504 Patent event code: PA03021R01I Comment text: Patent Application |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20170711 Patent event code: PE09021S01D |
|
| PG1501 | Laying open of application | ||
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20171124 Patent event code: PE09021S01D |
|
| E701 | Decision to grant or registration of patent right | ||
| PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20180327 |
|
| PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20180413 Patent event code: PR07011E01D |
|
| PR1002 | Payment of registration fee |
Payment date: 20180413 End annual number: 3 Start annual number: 1 |
|
| PG1601 | Publication of registration | ||
| PR1001 | Payment of annual fee |
Payment date: 20210503 Start annual number: 4 End annual number: 4 |
|
| PR1001 | Payment of annual fee |
Payment date: 20220413 Start annual number: 5 End annual number: 5 |
|
| PR1001 | Payment of annual fee |
Payment date: 20230403 Start annual number: 6 End annual number: 6 |
|
| PR1001 | Payment of annual fee |
Payment date: 20240409 Start annual number: 7 End annual number: 7 |
|
| PR1001 | Payment of annual fee |
Payment date: 20250401 Start annual number: 8 End annual number: 8 |

